mortality/aging
• pIpC-treated mice die within 30 days
|
hematopoietic system
• in pIpC-treated mice (including CFU-G, CFU-M, CFU-GM, and CFU-GEMM)
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• in pIpC-treated mice
|
• pIpC-treated mice exhibit a reduction of common myeloid progenitors (CMP), granulocyte-macrophage progenitors (GMP), and megakaryocyte-erythroid progenitors (MEP) compared with similarly treated control mice
|
immune system
• in pIpC-treated mice
|